Genotypic analysis of RTS,S/AS01 E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial.
Michal JuraskaAngela M EarlyLi LiStephen F SchaffnerMarc LievensAkanksha KhorgadeBrian SimpkinsNima S HejaziDavid BenkeserQi WangLaina D MercerSamuel AdjeiTsiri AgbenyegaScott AndersonDaniel AnsongDennis K BiiPatrick B Y BuabengSean EnglishNicholas FitzgeraldJonna GrimsbySimon K KariukiKephas OtienoFrançois RomanAaron M SamuelsNelli WestercampChristian F OckenhouseOpokua Ofori-AnyinamCynthia K LeeBronwyn L MacInnisDyann F WirthPeter B GilbertDaniel E NeafseyPublished in: The Lancet. Infectious diseases (2024)
GlaxoSmithKline Biologicals SA, PATH, Bill & Melinda Gates Foundation, and the German Federal Ministry of Education and Research.